Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)

SHE:301111 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	273.81	274.19	292.15	283.29	349.44	339.46
Other Revenue	4.45	4.45	0.25	0.05	0.35	1.5
Revenue	278.25	278.64	292.4	283.34	349.79	340.96
Revenue Growth (YoY)	-2.12%	-4.71%	3.20%	-19.00%	2.59%	7.70%
Cost of Revenue	91.09	89	94.55	92.74	107.53	114.8
Gross Profit	187.17	189.64	197.85	190.6	242.26	226.15
Selling, General & Admin	197.85	188.54	164.31	155.88	165.38	145.83
Research & Development	7.96	8.41	8.44	9.16	10.87	10.55
Other Operating Expenses	3.81	3.03	-0.62	1.72	4.71	4.44
Operating Expenses	209.54	198.36	173.39	166.77	181.75	161.83
Operating Income	-22.37	-8.71	24.46	23.83	60.51	64.33
Interest Expense	-3.05	-2.46	-0.37	-0.03	-0.06	-
Interest & Investment Income	10.58	12.45	14.6	14.25	4.03	1.78
Currency Exchange Gain (Loss)	-	-	-	-	-	-0.01
Other Non Operating Income (Expenses)	-2.11	-1.93	-1.01	-0.03	-0.04	-0.3
EBT Excluding Unusual Items	-16.95	-0.66	37.68	38.03	64.44	65.8
Gain (Loss) on Sale of Investments	0.96	1.67	2.78	2.93	1.55	0.29
Gain (Loss) on Sale of Assets	-	-	-	-0.33	-0.01	-0.25
Asset Writedown	-0.93	-1.02	-3.8	-8.4	-5.69	-
Other Unusual Items	0.03	-0.14	0.63	2.52	6.44	6.63
Pretax Income	-16.89	-0.14	37.29	34.75	66.72	72.46
Income Tax Expense	-2.56	-1.38	4.76	1.33	9.54	9.94
Earnings From Continuing Operations	-14.34	1.24	32.53	33.42	57.18	62.52
Minority Interest in Earnings	3.32	2.92	0.97	0	-	-
Net Income	-11.02	4.16	33.5	33.42	57.18	62.52
Net Income to Common	-11.02	4.16	33.5	33.42	57.18	62.52
Net Income Growth	-	-87.58%	0.25%	-41.56%	-8.54%	-6.17%
Shares Outstanding (Basic)	140	139	160	159	119	120
Shares Outstanding (Diluted)	140	139	160	159	119	120
Shares Change (YoY)	-12.75%	-13.02%	0.25%	33.59%	-0.92%	1.05%
EPS (Basic)	-0.08	0.03	0.21	0.21	0.48	0.52
EPS (Diluted)	-0.08	0.03	0.21	0.21	0.48	0.52
EPS Growth	-	-85.71%	-	-56.25%	-7.69%	-7.14%
Free Cash Flow	-49.32	-34.69	-51.41	64.34	68.54	44.8
Free Cash Flow Per Share	-0.35	-0.25	-0.32	0.40	0.57	0.37
Dividend Per Share	0.050	0.050	0.100	0.100	0.160	-
Dividend Growth	-50.00%	-50.00%	-	-37.50%	-	-
Gross Margin	67.27%	68.06%	67.66%	67.27%	69.26%	66.33%
Operating Margin	-8.04%	-3.13%	8.37%	8.41%	17.30%	18.87%
Profit Margin	-3.96%	1.49%	11.46%	11.79%	16.35%	18.34%
Free Cash Flow Margin	-17.72%	-12.45%	-17.58%	22.71%	19.59%	13.14%
EBITDA	-11.68	2	35.21	35.14	74.6	75.72
EBITDA Margin	-4.20%	0.72%	12.04%	12.40%	21.33%	22.21%
D&A For EBITDA	10.7	10.71	10.75	11.31	14.1	11.39
EBIT	-22.37	-8.71	24.46	23.83	60.51	64.33
EBIT Margin	-8.04%	-3.13%	8.37%	8.41%	17.30%	18.87%
Effective Tax Rate	-	-	12.76%	3.83%	14.30%	13.72%
Revenue as Reported	278.25	278.64	292.4	283.34	349.79	340.96

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.